Furthermore, considering CD39 expression might represent the existence of tumour-reactive T cells, which was the premise of reactivation, a combination of CD39, PD-L1 and TMB could better stratify patients who received ICIs and ACT. This evidence concerns the gene ENTPD1 and neoplasm.